title: VP22 light controlled delivery of oligonucleotides to ocular cells in vitro and in vivo.
abstract: OBJECTIVE
  To study VP22 light controlled delivery of antisense oligonucleotide (ODN) to ocular cells in vitro and in vivo.
  
  
  METHODS
  The C-terminal half of VP22 was expressed in Escherichia coli, purified and mixed with 20 mer phosphorothioate oligonucleotides (ODNs) to form light sensitive complex particles (vectosomes). Uptake of vectosomes and light induced redistribution of ODNs in human choroid melanoma cells (OCM-1) and in human retinal pigment epithelial cells (ARPE-19) were studied by confocal and electron microscopy. The effect of vectosomes formed with an antisense ODN corresponding to the 3'-untranslated region of the human c-raf kinase gene on the viability and the proliferation of OCM-1 cells was assessed before and after illumination. Cells incubated with vectosomes formed with a mismatched ODN, a free antisense ODN or a free mismatched ODN served as controls. White light transscleral illumination was carried out 24 h after the intravitreal injection of vectosomes in rat eyes. The distribution of fluorescent vectosomes and free fluorescent ODN was evaluated on cryosections by fluorescence microscopy before, and 1 h after illumination.
  
  
  RESULTS
  Overnight incubation of human OCM-1 and ARPE-19 cells with vectosomes lead to intracellular internalization of the vectosomes. When not illuminated, internalized vectosomes remained stable within the cell cytoplasm. Disruption of vectosomes and release of the complexed ODN was induced by illumination of the cultures with a cold white light or a laser beam. In vitro, up to 60% inhibition of OCM-1 cell proliferation was observed in illuminated cultures incubated with vectosomes formed with antisense c-raf ODN. No inhibitory effect on the OCM-1 cell proliferation was observed in the absence of illumination or when the cells are incubated with a free antisense c-raf ODN and illuminated. In vivo, 24 h after intravitreal injection, vectosomes were observed within the various retinal layers accumulating in the cytoplasm of RPE cells. Transscleral illumination of the injected eyes with a cold white light induced disruption of the vectosomes and a preferential localization of the "released" ODNs within the cell nuclei of the ganglion cell layer, the inner nuclear layer and the RPE cells.
  
  
  CONCLUSIONS
  In vitro, VP22 light controlled delivery of ODNs to ocular cells nuclei was feasible using white light or laser illumination. In vivo, a single intravitreal injection of vectosomes, followed by transscleral illumination allowed for the delivery of free ODNs to retinal and RPE cells.
authors.affiliation: INSERM U598, Paris, France.
authors.forename: Nadia
authors.initials: N
authors.lastname: Normand
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Valamanesh
authors.forename: Michèle
authors.initials: M
authors.lastname: Savoldelli
authors.forename: Frédéric
authors.initials: F
authors.lastname: Mascarelli
authors.forename: David
authors.initials: D
authors.lastname: BenEzra
authors.forename: Yves
authors.initials: Y
authors.lastname: Courtois
authors.forename: Francine
authors.initials: F
authors.lastname: Behar-Cohen
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002830:Choroid Neoplasms / Q000378:metabolism*; D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006801:Humans; D008027:Light; D008297:Male; D008545:Melanoma / Q000378:metabolism*; D018613:Microscopy, Confocal; D016376:Oligonucleotides, Antisense / Q000235:genetics* / Q000378:metabolism; D010750:Phosphoproteins / Q000235:genetics; D010857:Pigment Epithelium of Eye / Q000378:metabolism*; D019908:Proto-Oncogene Proteins c-raf / Q000235:genetics; D051381:Rats; D011917:Rats, Inbred Lew; D015678:Viral Structural Proteins / Q000235:genetics*
chemical_list: D016376:Oligonucleotides, Antisense; D010750:Phosphoproteins; D015678:Viral Structural Proteins; C073413:herpes simplex virus type 1 protein VP22; D019908:Proto-Oncogene Proteins c-raf